Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

The New Year began with two mid-size deals centered around the use of artificial intelligence (AI) in drug development. Sanofi...

Impressions : 754

BioMarin inks US$ 4.8 billion rare disease deal with Amicus; FDA approves pill version of Novo's Wegovy

PharmaCompass wishes its readers a very Happy New Year and brings news from the last two weeks in this double-dose edition of...

Impressions : 1085

FDA okays GSK's Exdensur as first biologic, add-on med for severe asthma; issues OAI status to Sun Pharma's India facility

As the year draws to a close, the US Food and Drug Administration (FDA) appears busy approving drugs at a fast pace. This week...

Impressions : 970

Lilly to invest US$ 6 bn in new API plant in Alabama; Biocon buys remaining stake in Biocon Biologics, makes it 100% subsidiary

In this week’s Phispers, Eli Lilly announced yet another investment in the US — this time to build its largest API ...

Impressions : 868

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Sanofi, Earendil Labs ink up to US$ 2.56 bn AI-driven autoimmune drug deal; CDC revises childhood immunization guidelines

BioMarin inks US$ 4.8 billion rare disease deal with Amicus; FDA approves pill version of Novo's Wegovy

FDA okays GSK's Exdensur as first biologic, add-on med for severe asthma; issues OAI status to Sun Pharma's India facility

Lilly to invest US$ 6 bn in new API plant in Alabama; Biocon buys remaining stake in Biocon Biologics, makes it 100% subsidiary

Ascent Pharms' Generics Topiramate Receives Approval in US

Respirent' Generics Fluticasone Propionate Receive Approval in US

Sentynl Theraps' Zycubo Receives Approval in US

Biocon Pharma's Generics Everolimus Receives Approval in US

Micro's Generics Sapropterin 2HCl Receives Approval in US

ScieGen's Generics Dapagliflozin Receive Tentative Approval in US

Micro's Generics Furosemide Receives Approval in US

Aurobindo's Generics Phenylbutyrate Receives Approval in US

Granules's Generics Amphetamine Receives Tentative Approval in US

Bpi's Generics Selenious Acid Receives Tentative Approval in US

Winder's Receives FDA Warning Letter

Chemspec Chemicals' Receives FDA Warning Letter

Purushothaman Damodara Kumaran's Receives FDA Warning Letter

Modern Recalls "Modern Warrior Ready" Dietary Supplement

Anthony Trinh Issues Nationwide Recall of Silintan Capsules

Asanuma Corporation is on FDA Import Alert List

FDA Issues Form 483 to Pure Indulgence Aesthetics

PLZ Corp. is on FDA Import Alert List

Veganic SKN Limited is on FDA Import Alert List

Cosmetic Manufacturers (Aust) Pty. is on FDA Import Alert List

Fresenius Kabi recognized as a Top Employer in 13 countries

US Healthcare Spending Soars to Over $5 Trillion in 2024

AbbVie Plans to Build Out Its Presence In Obesity Market

AJOVY Reduces Episodic Migraine Days in SPACE Trial

Ahmed Moussa Appointed Country Lead For Sanofi UK & Ireland

Orion Revises Nubeqa Annual Net Sales Forecast Timeline

Orion Provides Outlook for 2026 & Estimates Annual Nubeq Sale

Delhi HC Restores Ban On 2 Diabetes FDCs

AZ's $80B Revenue Target 'Very Much Within Reach,' CFO Says

Dr. Reddy's Announces First-to-Market Launch of Olopatadine HCl

Dr. Reddy's Announces First-to-Market Launch of Olopatadine HCl

Bionpharma Gets USFDA Nod For Etravirine Tablets With Steerlife

Allos Secures $5M For Causal AI In Drug Reformulation

Alembic Announces USFDA Tentative Approval For Bosutinib Tablets

Biocon Arm Gets USFDA Nod For Generic Everolimus Tablets

ChemWerth Appoints New GSM to Expand India Generic API Reach

FDA Confirms Para IV Patent Litigation for Brukinsa

FDA Confirms Para IV Patent Litigation for Livtencity

RVL Pharma: Santen Gets Japan Approval For UPNEEQ Mini

Granules India Secures USFDA Tentative Approval For gDYANAVEL XR

AJOVY Reduces Episodic Migraine Days in SPACE Trial

Trump Must Make Biotech Innovation A National Priority

GEA To Power New Biotechnology Fermentation Hub In Netherlands

JPM26, Day 3: Hundreds Attend Biotech CEO Sisterhood Meetup

Caldera Launches With $112M To Fund IBD Drug From China

JPM26, Day 3: Abbvie, AZ, Novo Execs Share Visions For '26

Evaxion Expands Ai-Immunology Platform Into Autoimmune Diseases

Pretzel Emerges As Winner From Rise And Fall Of Rome

JPM: Novo CSO Craves 'Different Flavors' Of Pipeline Innovation

Lyra Ditches Sole Rhinosinusitis Asset, Lays Off All Employees

Pharma, Med-Tech Firms Seek PLI Extension For APIs Coverage 2026

Supriya Lifescience Boosts Capacity And Global Readiness

How to Choose a Reliable Oxytetracycline HCL API Manufacture

Understanding Sevelamer Carbonate API COA Parameters

GMP Manufacturing Challenges in Tadalafil API Production

Understanding Latanoprost API COA Parameters

Government Eyes Separate Licensing for Bulk Drugs

Telangana Pharma Companies To Discuss Lalitpur Bulk Drugs Park

Pharma Exporters To Discuss API PLI Scheme With Korea

DoP Extends PLI Timeline for Bulk Drugs to Jan. 16, 2026

Delhi HC Restores Ban On 2 Diabetes FDCs

FDA Issues Warning Letters For GMP, GCP Violations

US FDA Requests Removal of Suicide Warnings From Weight-loss Drug

Telangana DCA Boosts Enforcement Through Global Synergy in 2025

Puducherry DC Dept Mandates 100% Testing to Fight Fakes

Quality Trailblazer Stresses Non-Negotiable Leadership Commitment

Global Drug Regulation Lessons From Nimesulide On Patient Safety

Aurobindo Pharma's Dyrupeg Faces Health Canada Compliance Notice

Haryana FDA Detects 33 Overpricing Violations In 2025

Telangana DCA Unveils Crackdown On Interstate Fake Medicine

US Healthcare Spending Soars to Over $5 Trillion in 2024

JPM: Illumina Working With China On Export Troubles, CEO Says

SOL Mental Health Celebrates Growth And Local Impact In 2025